Predictive Oncology Balance Sheet Health
Financial Health criteria checks 4/6
Predictive Oncology has a total shareholder equity of $2.0M and total debt of $195.8K, which brings its debt-to-equity ratio to 10%. Its total assets and total liabilities are $7.5M and $5.5M respectively.
Key information
10.0%
Debt to equity ratio
US$195.78k
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.08m |
| Equity | US$1.97m |
| Total liabilities | US$5.53m |
| Total assets | US$7.50m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: S1K's short term assets ($4.6M) exceed its short term liabilities ($3.8M).
Long Term Liabilities: S1K's short term assets ($4.6M) exceed its long term liabilities ($1.7M).
Debt to Equity History and Analysis
Debt Level: S1K has more cash than its total debt.
Reducing Debt: S1K's debt to equity ratio has reduced from 21.6% to 10% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: S1K has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: S1K has less than a year of cash runway if free cash flow continues to reduce at historical rates of 11.7% each year